Mitsubishi UFJ Trust & Banking Corp Sells 1,010 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Mitsubishi UFJ Trust & Banking Corp reduced its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.1% during the fourth quarter, Holdings Channel reports. The firm owned 31,372 shares of the biotechnology company’s stock after selling 1,010 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Axon Enterprise were worth $18,645,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. GQG Partners LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $478,349,000. Groupama Asset Managment bought a new stake in Axon Enterprise during the third quarter worth $200,000. Vanguard Group Inc. lifted its holdings in Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after acquiring an additional 275,959 shares during the period. Proficio Capital Partners LLC purchased a new position in Axon Enterprise in the fourth quarter worth $78,414,000. Finally, Assenagon Asset Management S.A. grew its stake in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of AXON opened at $550.65 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $42.19 billion, a price-to-earnings ratio of 142.29, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The stock’s 50-day simple moving average is $590.80 and its 200 day simple moving average is $546.79.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on AXON shares. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Needham & Company LLC reissued a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $604.67.

Insider Activity

In related news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.